December 4th 2023
As of last Friday, 117 people have been sickened, 61 hospitalized, and 2 people have died.
Community Practice Connections: Optimizing Recognition and Management of Acute Hepatic Porphyria
View More
State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
9th Annual School of Gastrointestinal Oncology® (SOGO®)
Register Now!
State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections
View More
4th Annual Live Medical Crossfire® IBS and IBD
View More
Expert Illustrations & Commentaries™: A Closer Look at Emerging Therapies in IBS-C
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago
View More
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
The Future of COVID-19 Vaccines, and Other Top Stories This Week
June 16th 2023This week, the FDA’s vaccine advisory committee unanimously voted the next generation of COVID-19 vaccines should be updated to a monovalent XBB strain. Read all about this and other top infectious disease headlines.
Read More
Rising Threat: Evaluating Salmonella Treatment Options Amid Antimicrobial Resistance
May 15th 2023Empiric therapy for severe Salmonella disease remains effective, but fluoroquinolone resistance calls for a shift towards trimethoprim-sulfamethoxazole as the preferred oral treatment for non-severe cases.
Read More
Patient Perspectives on Rectal Administration for Recurrent C difficile Infection
May 15th 2023A study of patients with recurrent Clostridioides difficile infection (rCDI) found that Rebyota, a rectally administered live biotherapeutic, was considered easy, quick, and appealing due to the lack of bowel preparation.
Read More
Seres Shares Trial Data for Vowst, the FDA-Approved Microbiome Therapeutic
May 8th 2023Recent phase 3 trial data for Vowst showed the microbiota-based therapeutic prevented recurrent C difficile infection in 91.3% of recipients after 8 weeks, a response that 94.6% of these patients maintained through week 24.
Read More